XML 57 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation - Stock Option Activity under All Plans and Other Grants (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Jun. 30, 2013
Mar. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]    
Number of Shares, Outstanding, Beginning Balance 1,231,498  
Number of Shares, Granted 158,000 551,000
Number of Shares, Exercised (49,167)  
Number of Shares, Canceled or expired (108,667)  
Number of Shares, Outstanding, Ending Balance 1,231,664 1,231,498
Number of Shares, Options exercisable at June 30, 2013 602,997  
Number of Shares, Unvested options expected to become exercisable after June 30, 2013 628,667  
Number of Shares, Shares available for future option grants at June 30, 2013 428,477  
Aggregate Intrinsic Value, Outstanding, Beginning Balance $ 720  
Aggregate Intrinsic Value, Granted     
Aggregate Intrinsic Value, Exercised 91  
Aggregate Intrinsic Value, Canceled or expired     
Aggregate Intrinsic Value, Outstanding, Ending Balance 1,093 720
Aggregate Intrinsic Value, Options exercisable at June 30, 2013 764  
Aggregate Intrinsic Value, Unvested options expected to become exercisable after June 30, 2013 $ 329  
Approximate Remaining Contractual Term, Granted 10 years  
Approximate Remaining Contractual Term, Outstanding 8 years 7 years
Approximate Remaining Contractual Term, Options exercisable at June 30, 2013 6 years  
Approximate Remaining Contractual Term, Unvested options expected to become exercisable after June 30, 2013 9 years  
Weighted-Average Exercise Price Outstanding, Beginning Balance $ 8.20  
Weighted-Average Exercise Price, Granted $ 8.58  
Weighted-Average Exercise Price, Exercised $ 6.80  
Weighted-Average Exercise Price, Canceled or expired $ 9.08  
Weighted-Average Exercise Price, Outstanding, Ending Balance $ 8.22 $ 8.20
Weighted-Average Exercise Price, Options exercisable at June 30, 2013 $ 8.17  
Weighted-Average Exercise Price, Unvested options expected to become exercisable after March 31, 2013 $ 8.28